Zobrazeno 1 - 6
of 6
pro vyhledávání: '"DeTolla LJ Jr"'
Autor:
Mamczarz J; Division of Translational Toxicology, University of Maryland School of Medicine, Baltimore, MD 21201, United States., Pescrille JD; Division of Translational Toxicology, University of Maryland School of Medicine, Baltimore, MD 21201, United States., Gavrushenko L; Division of Translational Toxicology, University of Maryland School of Medicine, Baltimore, MD 21201, United States., Burke RD; Division of Translational Toxicology, University of Maryland School of Medicine, Baltimore, MD 21201, United States., Fawcett WP; Division of Translational Toxicology, University of Maryland School of Medicine, Baltimore, MD 21201, United States., DeTolla LJ Jr; Program of Comparative Medicine and Departments of Pathology and Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, United States., Chen H; Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 21201, United States., Pereira EFR; Division of Translational Toxicology, University of Maryland School of Medicine, Baltimore, MD 21201, United States., Albuquerque EX; Division of Translational Toxicology, University of Maryland School of Medicine, Baltimore, MD 21201, United States. Electronic address: ealbuquerque@som.umaryland.edu.
Publikováno v:
Neurotoxicology [Neurotoxicology] 2016 Sep; Vol. 56, pp. 17-28. Date of Electronic Publication: 2016 Jun 11.
Autor:
Pereira EF; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Aracava Y; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., DeTolla LJ Jr; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Beecham EJ; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Basinger GW Jr; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Wakayama EJ; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.)., Albuquerque EX; Division of Translational Toxicology, Department of Epidemiology and Public Health (E.F.R.P., Y.A., E.X.A.), and Program of Comparative Medicine and Departments of Pathology, Medicine, and Epidemiology and Public Health (L.J.D.), University of Maryland School of Medicine, Baltimore, Maryland; Countervail Corporation, Charlotte, North Carolina (E.J.B., G.W.B.); and Biomedical Advanced Research and Development Authority and Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC (E.J.W.) ealbuquerque@som.umaryland.edu.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2014 Aug; Vol. 350 (2), pp. 313-21. Date of Electronic Publication: 2014 Jun 06.
BfpU, a soluble protein essential for type IV pilus biogenesis in enteropathogenic Escherichia coli.
Autor:
Schreiber W; Molecular and Cellular Biology Program, Division of Infectious Diseases1 and Comparative Medicine Program, Department of Medicine,2 University of Maryland, Baltimore, School of Medicine, Baltimore, MD 21201, USA., Stone KD; Molecular and Cellular Biology Program, Division of Infectious Diseases1 and Comparative Medicine Program, Department of Medicine,2 University of Maryland, Baltimore, School of Medicine, Baltimore, MD 21201, USA., Strong MA; Molecular and Cellular Biology Program, Division of Infectious Diseases1 and Comparative Medicine Program, Department of Medicine,2 University of Maryland, Baltimore, School of Medicine, Baltimore, MD 21201, USA., DeTolla LJ Jr; Molecular and Cellular Biology Program, Division of Infectious Diseases1 and Comparative Medicine Program, Department of Medicine,2 University of Maryland, Baltimore, School of Medicine, Baltimore, MD 21201, USA., Hoppert M; Institut für Mikrobiologie und Genetik, Georg-August Universität, Grisebachstrasse 8, 37077 Göttingen, Germany3., Donnenberg MS; Molecular and Cellular Biology Program, Division of Infectious Diseases1 and Comparative Medicine Program, Department of Medicine,2 University of Maryland, Baltimore, School of Medicine, Baltimore, MD 21201, USA.
Publikováno v:
Microbiology (Reading, England) [Microbiology (Reading)] 2002 Aug; Vol. 148 (Pt 8), pp. 2507-2518.
Autor:
DeTolla LJ Jr
Publikováno v:
Journal of the American Veterinary Medical Association [J Am Vet Med Assoc] 1996 Aug 01; Vol. 209 (3), pp. 546; author reply 550-2.
Autor:
Sacci JB Jr; University of Maryland School of Medicine, Baltimore 21201., Schriefer ME, Resau JH, Wirtz RA, Detolla LJ Jr, Markham RB, Azad AF
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 1992 May 01; Vol. 89 (9), pp. 3701-5.
Autor:
DeTolla LJ Jr; Department of Zoology and Bureau of Biological Research, Rutgers University, New Brunswick, New Jersey 08903, USA., Semprevivo LH, Palczuk NC, Passmore HC
Publikováno v:
Immunogenetics [Immunogenetics] 1980; Vol. 10 (4), pp. 353-61.